Dispensing of long-term treatments for multiple sclerosis in the pharmacy

被引：0
|
作者：
Voirin, Maelle [1 ]
机构：
[1] 65 Ave Raymond Poincare, F-21000 Dijon, France
来源：
ACTUALITES PHARMACEUTIQUES | 2018年 / 57卷 / 573期
关键词：
adverse effect; compliance; dispensing; injectable biotherapy; oral form; treatment switching;
D O I：
10.1016/j.actpha.2017.11.026
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The therapeutic armamentarium for patients with multiple sclerosis has evolved over recent years. When dispensing long-term treatments, pharmacists must inform and advise, optimise the management of the treatment, detect adverse effects and ensure compliance. When a treatment is changed, the monitoring must be stepped up. (c) 2017 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：26 / 30
页数：5
相关论文
共 50 条
  • [21] Natalizumab in Multiple Sclerosis: Long-Term Management
    Clerico, Marinella
    Artusi, Carlo Alberto
    Di Liberto, Alessandra
    Rolla, Simona
    Bardina, Valentina
    Barbero, Pierangelo
    De Mercanti, Stefania Federica
    Durelli, Luca
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (05)
  • [22] Progression in multiple sclerosis - a long-term problem
    Bittner, Stefan
    Zipp, Frauke
    CURRENT OPINION IN NEUROLOGY, 2022, 35 (03) : 293 - 298
  • [23] New treatments for multiple sclerosis at what long-term risk? (vol 89, pg 225, 2014)
    Cameron, M. H.
    Bourdette, D.
    LANCET NEUROLOGY, 2014, 13 (05): : 446 - 446
  • [24] Multiple sclerosis. Rehabilitation and long-term course
    Beer, S.
    Kesselring, J.
    OPHTHALMOLOGE, 2014, 111 (08): : 715 - 721
  • [25] Vitamin D and Long-Term Memory in Multiple Sclerosis
    Koven, Nancy S.
    Cadden, Margaret H.
    Murali, Sangita
    Ross, Mitchell K.
    COGNITIVE AND BEHAVIORAL NEUROLOGY, 2013, 26 (03) : 155 - 160
  • [26] Depression in multiple sclerosis: A long-term longitudinal study
    Koch, Marcus W.
    Patten, Scott
    Berzins, Sandy
    Zhornitsky, Simon
    Greenfield, Jamie
    Wall, Winona
    Metz, Luanne M.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (01) : 76 - 82
  • [27] LONG-TERM TREATMENT OF FATIGUE IN MULTIPLE-SCLEROSIS
    MURRAY, TJ
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1985, 12 (02) : 201 - 201
  • [28] Long-term effects of dalfampridine in patients with multiple sclerosis
    Ruck, T.
    Bittner, S.
    Simon, O. J.
    Goebel, K.
    Wiendl, H.
    Schilling, M.
    Meuth, S. G.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2014, 337 (1-2) : 18 - 24
  • [29] Early prediction of long-term evolution of multiple sclerosis
    Bergamaschi, R
    Trojano, M
    Amato, M
    Quaglini, S
    Cosi, V
    MULTIPLE SCLEROSIS, 2005, 11 : S99 - S99
  • [30] Survival: the ultimate long-term outcome in multiple sclerosis
    Giovannoni, Gavin
    BRAIN, 2019, 142 : 1166 - 1167
12345